Search

Your search keyword '"Milionis, H"' showing total 771 results

Search Constraints

Start Over You searched for: Author "Milionis, H" Remove constraint Author: "Milionis, H"
771 results on '"Milionis, H"'

Search Results

2. Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023

4. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

6. A second update on mapping the human genetic architecture of COVID-19

7. Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19 – Corrigendum

10. Comparative effect of 3 different fix-combination antihypertensive treatments in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

11. A population-based study to estimate the incidence rate of hospitalized community-acquired pneumonia in adults in Greece

12. Patients with COVID-19 versus non-COVID-19 community-acquired pneumonia

13. Association of patient characteristics with clinical outcomes in a cohort of hospitalised patients with SARS-CoV-2 infection in a Greek referral centre for COVID-19.

14. Comparative effect of delapril-manidipine treatment versus valsartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

15. Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients

16. Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

17. Laboratory findings and clinical outcomes of 681 COVID-19 patients with dyslipidemia requiring hospitalization

18. The possible role of TyG index and TRG/HDL, CRP/HDL, NEUTROPHILS/HDL lymphocytes/HDL ratios in disease severity and outcomes in COVID-19 hospitalized patients with arterial hypertension

20. Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients

21. Comparative effect of delapril-manidipine treatment versus valsartan-amlodipine treatment in HOMA-IR, HOMA-B, HOMA-S and QUICKI indexes in prediabetic hypertensive patients

22. Association of cardiovascular risk factors and olfactory or taste dysfunction in COVID-19 population. Data from an academic center in Greece

23. Thrombotic and thromboembolic events in COVID-19 patients: Association with clinical presentation, progression and laboratory findings. Data analysis of a 681 patient cohort

24. Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

27. Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with valsartan/amlodipine in prediabetic hypertensive patients

28. Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with telmisartan/amlodipine in prediabetic patients

29. Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with valsartan/amlodipine in prediabetic patients

30. Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with telmisartan/amlodipine in prediabetic hypertensive patients

31. Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with manidipine/delapril in prediabetic hypertensive patients

32. Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with delapril/manidipine in prediabetic hypertensive patients

34. Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study

35. Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure

36. Application of a home-based exercise program combined with tele-rehabilitation in previously hospitalized patients with COVID-19: A feasibility, single-cohort interventional study

37. Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19

38. Stroke Units Necessity for Patients, Web- Based SUN4P Registry: Descriptive Characteristics of the Population

39. Inpatient Cost of Stroke Care in Greece: Preliminary Results of the Web-Based SUN4P Registry

48. Recommendations for lipid modification in patients with ischemic stroke or transient ischemic attack: A clinical guide by the Hellenic Stroke Organization and the Hellenic Atherosclerosis Society

49. Paraneoplastic intrahepatic cholestasis in supradiaphragmatic classical hodgkin lymphoma successfully treated with brentuximab vedotin: A case report and review of the literature

50. Statin treatment and outcomes after embolic stroke of undetermined source

Catalog

Books, media, physical & digital resources